X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-06 | BEAM | Ciaramella Giuseppe | Pres | S - Sale | $26.36 | -51,110 | 109,150 | -32% | -$1,347,050 | ||||||
D | 2024-10-14 | BEAM | Ciaramella Giuseppe | Pres | S - Sale+OE | $26.27 | -51,110 | 160,260 | -24% | -$1,342,752 | |||||
2024-10-01 | BEAM | Bellon Christine | GC | S - Sale | $23.48 | -385 | 104,209 | 0% | -$9,040 | ||||||
2024-10-01 | BEAM | Cavanagh Bethany J | SVP, Finance, Treasurer | S - Sale | $23.48 | -289 | 44,931 | -1% | -$6,785 | ||||||
2024-09-30 | BEAM | Evans John M. | CEO | S - Sale | $24.60 | -60,000 | 1,041,659 | -5% | -$1,476,024 | ||||||
M | 2024-07-01 | BEAM | Simon Amy | Chief Medical Officer | S - Sale | $23.28 | -1,250 | 68,805 | -2% | -$29,094 | |||||
2024-06-27 | BEAM | Evans John M. | CEO | S - Sale | $24.50 | -60,000 | 1,101,343 | -5% | -$1,470,156 | ||||||
M | 2024-04-01 | BEAM | Simon Amy | Chief Medical Officer | S - Sale | $31.02 | -23,687 | 70,060 | -25% | -$734,805 | |||||
2024-04-01 | BEAM | Bellon Christine | GC | S - Sale | $32.12 | -3,401 | 104,594 | -3% | -$109,240 | ||||||
2024-04-01 | BEAM | Burrell Terry-Ann | CFO | S - Sale | $32.12 | -5,446 | 70,137 | -7% | -$174,926 | ||||||
D | 2024-04-01 | BEAM | Evans John M. | CEO | S - Sale+OE | $32.13 | -18,102 | 1,161,343 | -2% | -$581,617 | |||||
D | 2024-04-01 | BEAM | Ciaramella Giuseppe | Pres | S - Sale+OE | $32.12 | -4,534 | 169,616 | -3% | -$145,632 | |||||
2024-03-28 | BEAM | Evans John M. | CEO | S - Sale | $33.86 | -60,000 | 1,179,445 | -5% | -$2,031,402 | ||||||
M | 2024-02-13 | BEAM | Fmr LLC | See Remark 1 | S - Sale | $30.55 | -901,565 | 4,007,424 | -18% | -$27,545,051 | |||||
D | 2024-01-31 | BEAM | Evans John M. | CEO | S - Sale+OE | $25.33 | -60,000 | 1,161,262 | -5% | -$1,519,800 | |||||
2024-01-03 | BEAM | Bellon Christine | GC | S - Sale | $26.42 | -1,907 | 80,495 | -2% | -$50,383 | ||||||
D | 2023-11-20 | BEAM | Bellon Christine | GC | S - Sale+OE | $30.50 | -10,000 | 82,402 | -11% | -$305,000 | |||||
2023-10-30 | BEAM | Simon Amy | Chief Medical Officer | S - Sale | $18.70 | -3,448 | 65,469 | -5% | -$64,478 | ||||||
2023-10-02 | BEAM | Bellon Christine | GC | S - Sale | $22.85 | -388 | 82,402 | 0% | -$8,866 | ||||||
2023-07-10 | BEAM | Simon Amy | Chief Medical Officer | S - Sale | $30.48 | -391 | 68,917 | -1% | -$11,918 | ||||||
DM | 2023-07-21 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $32.06 | -156,530 | 48,250 | -76% | -$5,018,292 | |||||
M | 2023-04-03 | BEAM | Evans John M. | CEO | S - Sale | $29.63 | -11,654 | 1,220,979 | -1% | -$345,334 | |||||
M | 2023-04-03 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale | $29.73 | -3,672 | 112,290 | -3% | -$109,164 | |||||
M | 2023-04-03 | BEAM | Bellon Christine | GC | S - Sale | $29.63 | -2,092 | 82,790 | -2% | -$61,996 | |||||
M | 2023-04-03 | BEAM | Simon Amy | Chief Medical Officer | S - Sale | $29.87 | -16,099 | 69,308 | -19% | -$480,843 | |||||
M | 2023-04-03 | BEAM | Burrell Terry-Ann | CFO | S - Sale | $29.74 | -4,640 | 47,117 | -9% | -$137,978 | |||||
DM | 2023-01-26 | BEAM | Burrell Terry-Ann | CFO | S - Sale+OE | $45.08 | -37,254 | 31,277 | -54% | -$1,679,510 | |||||
DM | 2023-01-23 | BEAM | Burrell Terry-Ann | CFO | S - Sale+OE | $45.02 | -20,236 | 31,277 | -39% | -$910,947 | |||||
D | 2023-01-18 | BEAM | Burrell Terry-Ann | CFO | S - Sale+OE | $45.14 | -47,195 | 31,277 | -60% | -$2,130,382 | |||||
D | 2023-01-03 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $37.46 | -53,729 | 95,962 | -36% | -$2,012,490 | |||||
D | 2022-12-12 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $42.70 | -51,015 | 91,462 | -36% | -$2,178,229 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |